F-star Therapeutics
Pre-clinicalDevelops bispecific antibodies for cancer immunotherapy using its proprietary Fcab and mAb2 platforms.
Founded
2006
Focus
AntibodiesBiologics
About
Develops bispecific antibodies for cancer immunotherapy using its proprietary Fcab and mAb2 platforms.
Funding History
4Total raised: $247M
IPO$75MUndisclosedJul 15, 2020
Series C$80MNovo VenturesJul 15, 2018
Series B$60MNovo VenturesJun 15, 2015
Series A$32MSR OneJan 15, 2012
Company Info
TypePrivate
Founded2006
LocationCambridge, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile